• Sign In
  • Register
  • Glossary
  • Share/Bookmark
  • RSS
All About Bleeding
Path Link

Acquired Bleeding

Newsroom

Get the latest news about CSL, bleeding disorders, industry research and development and more.

Learn More

CSL Behring & Therapies

Coagulation therapy is the foundation of CSL Behring’s broad range of therapies.

Learn More

First Aid Card

Create and print your own first aid card.

Learn More

Bleeding disorders are often inherited, but about a third of hemophilia A cases are caused by a new mutation (de novo). Acquired bleeding may occur later in life as a result of factors such as medication intake, cancer or immunological diseases.

Acquired bleeding is not inherited, or passed through families, like most bleeding disorders. Several medical conditions may trigger interaction with or formation of antibodies against either coagulation factor. The antibodies inactivate the coagulation factor, and bleeding symptoms may occur. Acquired bleeding disorders affect men and women equally, and the potential for significant bleeding problems is high.

Potential Causes of Acquired Bleeding

Another, much more common cause of acquired bleeding is the impact of certain drugs that suppress the production of coagulation factors, such as coumarin derivates like warfarin. Patients that receive these drugs have reduced concentrations of coagulation factors II, VII, IX and X. Overdosing of warfarin or surgical intervention in these patients can lead to life-threatening bleeding conditions. Therefore, such patients require tight monitoring of their coagulation status in order to avoid bleeding. Before surgery, these patients need anticoagulant reversal in order to restore normal coagulation.

Accidents and surgical interventions in general can also lead to massive blood loss and subsequently to a critical reduction in coagulation factors. In addition to bleeding caused by the injury or the surgical intervention itself (surgical bleeding), the critical reduction in the level of coagulation factors can lead to additional non-surgical bleeding complications that can be difficult to control (e.g., coagulopathic bleeding). Such patients can have critically low concentrations of basically all coagulation factors. In general, it is necessary to replace coagulation factors with allogenic blood products or coagulation factor concentrates in order to reverse the critical condition.


Last Updated: 11/4/2012 4:35 PM
  • E-mail
  • Print
  • Share